Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

For that, Nektar shoulders the blame: it developed not only the powdered insulin formulation of Exubera but also the inhaler, which was an early design. Does Exubera's flameout mean the end for ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.